Strength
2.5 mg/1
Manufacturer
AvPAKNDC
50268056115
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MIDODRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077746On Market Since
8/26/2019
Pharmacological Classes
Price Statistics
The NADAC for MIDODRINE HCL 2.5 MG TABLET has been published 344 times since Nov 27, 2019, and over the history we have for it it has declined 78.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0717 per EA |
|---|---|
| All-time high | $0.4071 (Apr 15, 2020) |
| All-time low | $0.0668 (Nov 20, 2024) |
| 52-week high | $0.0857 |
| 52-week low | $0.0712 |
| Median price | $0.1774 |
| Average price | $0.1735 |
| Largest weekly change | +59.2% (Nov 22, 2023) |
| Weeks tracked | 344 |
| Tracking since | Nov 27, 2019 |
Generic Alternatives
The matcher finds 11 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MIDODRINE HCL 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MIDODRINE HCL 2.5 MG TABLET, manufactured by AvPAK, is $0.0717 per EA (NDC 50268056115), effective Jun 24, 2026.
How has the price of MIDODRINE HCL 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for MIDODRINE HCL 2.5 MG TABLET has declined 78.7%. It has been tracked across 344 weekly CMS publications since Nov 27, 2019.
What are the highest and lowest recorded NADAC prices for MIDODRINE HCL 2.5 MG TABLET?
Since Nov 27, 2019, the NADAC for MIDODRINE HCL 2.5 MG TABLET has ranged from a low of $0.0668 (Nov 20, 2024) to a high of $0.4071 (Apr 15, 2020), with a median of $0.1774 per EA.
Are there cheaper alternatives to MIDODRINE HCL 2.5 MG TABLET?
11 NADAC-published products share the same active ingredient, strength, and dosage form as MIDODRINE HCL 2.5 MG TABLET, but none are currently priced below it.
Who manufactures MIDODRINE HCL 2.5 MG TABLET?
MIDODRINE HCL 2.5 MG TABLET (NDC 50268056115) is labeled by AvPAK, and CMS classifies it as a generic product.
Related Drugs
Same classification